Brain Cancer Canada Awards Grant for Innovative Medical Avatar Technology to Improve Treatments in High Grade Gliomas like Glioblastoma
May 16 2024 - 8:45AM
Brain Cancer Canada is proud to announce the awarding of a $64,000
research grant to Dr. Claire Dubois, PhD, Professor at the
Université de Sherbrooke – Faculty of Medicine and Health Sciences
(FMSS) and her team, investigating a ground-breaking approach in
the treatment of malignant gliomas. High grade gliomas can spread
rapidly through brain tissue which typically leads to very poor
prognosis for patients. The grant supports the innovative
Sherbrooke Brain Cancer Avatar Initiative, employing novel
CAMavatar technology.
This project, titled "Medical Technology Based on the Chicken
Embryo-patient Avatar for Improving Drug Treatment for Glioma
Patients," aims to transform the treatment paradigm for patients
with high-grade gliomas. CAMavatar technology utilizes the chick
embryo chorioallantoic membrane (CAM) model to test drug responses
quickly and without the ethical concerns and high costs associated
with traditional models.
Dr. Dubois highlights the potential impact of the research: "We
believe that our CAMavatar technology will give high-grade glioma
patients their best chance at survival by identifying the most
effective treatment for each patient. This could dramatically
transform the clinical management of gliomas, offering personalized
therapies that are tailored to the unique characteristics of each
tumor."
Angela Scalisi, Chair of Brain Cancer Canada, expressed her
enthusiasm for the project, stating, "We are excited to support
this innovative technology that perfectly aligns with our mission
to drive transformative research in brain cancer treatment. This
grant, made possible by the generous contributions of our founding
sponsor Scotia Wealth Management, and Brain Cancer Canada corporate
and personal donors, underscores our commitment to pioneering
approaches that can significantly enhance patient outcomes."
The CAMavatar technology has the possibility of not only
accelerating the process of identifying and personalizing effective
treatments, but also reducing reliance on traditional animal
testing, aligning with global efforts to improve animal welfare in
research.
This funding is part of Brain Cancer Canada's broader initiative
during May's Brain Cancer Awareness Month, known as "Go Grey in
May." This is the second of four major grants issued by Brain
Cancer Canada this month, highlighting its commitment to advancing
research and support for brain cancer patients.
For more detailed information on the Sherbrooke Brain Cancer
Avatar Initiative and to understand more about how this research is
revolutionizing the fight against gliomas, please contact
sac@braincancercanada.ca
About Brain Cancer Canada
Brain Cancer Canada is a national charity dedicated to
supporting individuals diagnosed with malignant brain tumors.
Through funding innovative research, technology, and treatments,
Brain Cancer Canada aims to improve survival rates and the quality
of life for patients, while providing essential support to their
families.
Media Contact:
media@braincancercanada.ca